FDA appears to hold off on crackdown on synthetic nicotine products; Biden signs order on abortion access

There are growing signs the FDA is not ready to crack down on vape companies skirting the agency's rules. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      FDA appears to hold off on crackdown on synthetic nicotine products, despite calls from Congress By Nicholas Florko Marshall Ritzel/AP Advocates are apoplectic that the agency has not taken action to date against any company that hasn't submitted a marketing application. Read More Biden signs order on abortion access after Supreme Court ruling By Seung Min Kim, Zeke Miller, and Chris Megerian — Associated Press Evan Vucci/AP The actions President Biden outlined are limited in their ability to safeguard access to abortion nationwide. Read More Scientists design a cheap device that can detect ear problems with the help of a smartphone By Edward Chen Adobe Tympanometers to detect hearing problems can cost thousands. So engineers designed a version that costs $28 when paired with a smartphone. Read More Sponsor content by YouTube Increasing access to authoritative health information through video People around the world need better access to high quality health information. That's why YouTube Health is working with the National Health Service to make it easier for people to find information from authoritative sources on YouTube. New features launched in the United Kingdom show labels on videos from authoritative sources, and videos from these sources may be shown in shelves for certain health-related search queries on YouTube. Learn more. STAT+: Drug companies will have to start refunding Medicare for certain drugs that get thrown out By Bob Herman Adobe Starting in 2023, Medicare will be refunded for the unused portions of injectable and infused drugs administered by physicians in outpatient clinics. Read More Opinion: STAT+: How pharma and biotech can keep innovating in a bear market By Shane Kovacs Adobe Biotech and pharma companies can make the best of a bear market to sharpen their focus and emerge from it with a stronger trajectory. Read More Opinion: Real-world evidence must not become evidence for abortion-related prosecution By Eric D. Perakslis adobe The Supreme Court's decision on abortion should change how health systems think about sharing and monetizing real-world evidence. Read More Friday, July 8, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser